A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
about
Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial dataIron therapy for pre-operative anaemiaIron therapy for pre-operative anaemiaIron therapy in anaemic adults without chronic kidney diseaseEfficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemiaThe role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal diseaseIntravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsIron deficiency anemia in inflammatory bowel diseaseFerrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysisAnemia in inflammatory bowel disease: a neglected issue with relevant effectsSafety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trialsPrevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. ironSF-36 total score as a single measure of health-related quality of life: Scoping reviewAnemia and iron deficiency in gastrointestinal and liver conditionsCorrecting iron deficiencyIron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysisEfficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled TrialsIron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?Intravenous iron therapy: how far have we come?Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled studySafety and Efficacy of Ferric Carboxymaltose in Anemic Pregnant Women: A Retrospective Case Control StudyEffect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemiaFerric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds.Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective.Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners.Treatment of iron deficiency anemia associated with gastrointestinal tract diseases.Alternative procedures for reducing allogeneic blood transfusion in elective orthopedic surgery.Diagnosis and management of iron deficiency anemia in patients with IBD.Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project.Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group RecommendationsEfficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral ironWhen is high-dose intravenous iron repletion needed? Assessing new treatment options.Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases.A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients.Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.Role of preoperative intravenous iron therapy to correct anemia before major surgery: study protocol for systematic review and meta-analysis.
P2860
Q21261840-265616A9-8F4A-4D97-9027-82A162C57F4EQ24186952-D0217013-1810-44F6-B31F-88314701F827Q24186979-637CF946-6D8B-434C-96CE-515936E1A4AFQ24187098-E3F062C0-A017-422D-A4F9-4864DB1D9ECBQ26750413-C7C5E8D1-1B40-46BA-A789-FCADA69BCEC1Q26771882-0D2EEB5B-1826-4739-AB93-3C8FB972B4F6Q26772074-0BD39541-33A4-4F8F-9F6E-7F5DFDE48DB8Q26795390-EC93816C-5BF3-4215-BA95-C9D1C35A1819Q26822051-C794F56D-C446-4ADB-AD88-29B25F2F2094Q26822906-7FDB7BE7-F5D4-4E77-910E-37053F1F2F3FQ26829377-F6E10C1D-EF6B-4362-9E4A-9C79C0721C5BQ27004170-9DA777F5-7227-44F3-9D20-11C559488CCEQ28066146-068DB2E4-3E7D-4174-9DC1-B7E793F09864Q28069820-CDC37AB3-18B7-44F1-B6D5-854A7CE4631FQ28076150-94A9E5FD-513B-4DCE-9FF7-098D595E6AE4Q28082489-A60F8689-A3C6-457E-95C7-4646E34BC9C1Q28085514-10B8F660-D0C6-4EE8-84A3-8021B4B557CEQ28088503-0B517210-4545-44DD-9A63-0F7112BE4E4BQ28276678-75F4D8AB-76AC-4FA7-B4A2-0B45E6367253Q28538067-0EC901F3-36C5-4A2C-B738-49DDA3B64A27Q28606630-E2B51FF5-E18C-43ED-8F32-69CDEEA244C5Q28730674-4CE03269-D0C3-4747-BDCC-898D36FCC00BQ31103631-4A391C7F-1E98-4E35-A60E-97EBE0DCCDA1Q33583025-72155D0C-A110-4E8D-B800-38B26C73EFA9Q33658410-C3B3ABFB-4418-40E7-8AD8-AD721F136EE8Q33700880-B0601FD3-F152-4D07-ACDE-D616ABE2ECD4Q33903592-7C9AD5D9-27A5-4125-9E50-5BA10D05423BQ34079843-5EAFEB24-DB02-4E1F-8A30-A53905FF8310Q34141999-A79DACAE-C1C4-4B61-82B1-4961A540114AQ34165670-EF3EF02F-5441-4C62-852F-A1300D5B0DDCQ34429565-0D497A62-D04D-4024-A099-90F4235AF68CQ34466623-8F4C427E-30E3-423A-942E-77910625823AQ34470847-EE2D4422-507B-4AE6-877E-80092D3C4306Q34574079-7897A9AE-1EF5-4239-BC15-0B18B0E9718EQ34654443-C3BD0DB7-B46F-466A-B8D3-A31AD648BE7BQ34700903-9B234E64-8DE6-43AC-B4A0-FCF5D2152D2DQ34867539-DA6A3FF5-90B3-467D-8CFC-91F81EC22688Q34885195-0C898840-775D-42B6-A874-3B71C6F03774Q35126117-609E170A-2D6B-42E2-8130-B3F36C0AAAC1Q35206582-BC054FF9-DE21-4237-BFA5-B01FF7E3F830
P2860
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A novel intravenous iron formu ...... ) randomized controlled trial.
@ast
A novel intravenous iron formu ...... ) randomized controlled trial.
@en
A novel intravenous iron formu ...... ase: the ferric carboxymaltose
@nl
type
label
A novel intravenous iron formu ...... ) randomized controlled trial.
@ast
A novel intravenous iron formu ...... ) randomized controlled trial.
@en
A novel intravenous iron formu ...... ase: the ferric carboxymaltose
@nl
prefLabel
A novel intravenous iron formu ...... ) randomized controlled trial.
@ast
A novel intravenous iron formu ...... ) randomized controlled trial.
@en
A novel intravenous iron formu ...... ase: the ferric carboxymaltose
@nl
P2093
P2860
P1476
A novel intravenous iron formu ...... ) randomized controlled trial.
@en
P2093
Alicia M Sambuelli
Christoph Gasche
Larisa V Dudar
Luis Chaires Garcia
Simeon Stoinov
Stefanie Kulnigg
Vladimir Simanenkov
Waldemar Karnafel
P2860
P304
P356
10.1111/J.1572-0241.2007.01744.X
P407
P577
2008-03-26T00:00:00Z